151 related articles for article (PubMed ID: 38167321)
1. Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platforms.
Furuya H; Sakatani T; Tanaka S; Murakami K; Waldron RT; Hogrefe W; Rosser CJ
J Transl Med; 2024 Jan; 22(1):8. PubMed ID: 38167321
[TBL] [Abstract][Full Text] [Related]
2. Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platforms.
Furuya H; Sakatani T; Tanaka S; Murakami K; Waldron RT; Hogrefe W; Rosser CJ
Res Sq; 2023 Nov; ():. PubMed ID: 38045238
[TBL] [Abstract][Full Text] [Related]
3. Analytical validation of ONCURIA™ a multiplex bead-based immunoassay for the non-invasive bladder cancer detection.
Furuya H; Tabula L; Lee R; Kralovec P; Ramsden M; Wong R; Rosser CJ
Pract Lab Med; 2020 Nov; 22():e00189. PubMed ID: 33294574
[TBL] [Abstract][Full Text] [Related]
4. Multiplex protein signature for the detection of bladder cancer in voided urine samples.
Rosser CJ; Ross S; Chang M; Dai Y; Mengual L; Zhang G; Kim J; Urquidi V; Alcaraz A; Goodison S
J Urol; 2013 Dec; 190(6):2257-62. PubMed ID: 23764080
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Commercial ELISA Kits, a Prototype Multiplex Electrochemoluminescent Assay, and a Multiplex Bead-Based Immunoassay for Detecting a Urine-Based Bladder-Cancer-Associated Diagnostic Signature.
Furuya H; Pagano I; Chee K; Kobayashi T; Wong RS; Lee R; Rosser CJ
Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31671775
[TBL] [Abstract][Full Text] [Related]
6. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.
Lasseter HC; Provost AC; Chaby LE; Daskalakis NP; Haas M; Jeromin A
Cytokine X; 2020 Jun; 2(2):100027. PubMed ID: 33604555
[TBL] [Abstract][Full Text] [Related]
7. A multi-analyte assay for the non-invasive detection of bladder cancer.
Goodison S; Chang M; Dai Y; Urquidi V; Rosser CJ
PLoS One; 2012; 7(10):e47469. PubMed ID: 23094052
[TBL] [Abstract][Full Text] [Related]
8. A multiplex immunoassay for the non-invasive detection of bladder cancer.
Shimizu Y; Furuya H; Bryant Greenwood P; Chan O; Dai Y; Thornquist MD; Goodison S; Rosser CJ
J Transl Med; 2016 Jan; 14():31. PubMed ID: 26830497
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ
Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer.
Hirasawa Y; Pagano I; Chen R; Sun Y; Dai Y; Gupta A; Tikhonenkov S; Goodison S; Rosser CJ; Furuya H
J Transl Med; 2021 Apr; 19(1):141. PubMed ID: 33823873
[TBL] [Abstract][Full Text] [Related]
11. Development of a bead-based multiplex assay for the simultaneous detection of porcine inflammation markers using xMAP technology.
Bongoni AK; Lanz J; Rieben R; Banz Y
Cytometry A; 2013 Jul; 83(7):636-47. PubMed ID: 23576245
[TBL] [Abstract][Full Text] [Related]
12. A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort.
Goodison S; Ogawa O; Matsui Y; Kobayashi T; Miyake M; Ohnishi S; Fujimoto K; Dai Y; Shimizu Y; Tsukikawa K; Furuya H; Rosser CJ
J Transl Med; 2016 Oct; 14(1):287. PubMed ID: 27717367
[TBL] [Abstract][Full Text] [Related]
13. Conversion of a capture ELISA to a Luminex xMAP assay using a multiplex antibody screening method.
Baker HN; Murphy R; Lopez E; Garcia C
J Vis Exp; 2012 Jul; (65):. PubMed ID: 22806215
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronidase treatment of synovial fluid to improve assay precision for biomarker research using multiplex immunoassay platforms.
Jayadev C; Rout R; Price A; Hulley P; Mahoney D
J Immunol Methods; 2012 Dec; 386(1-2):22-30. PubMed ID: 22955210
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology.
Kofoed K; Schneider UV; Scheel T; Andersen O; Eugen-Olsen J
Clin Chem; 2006 Jul; 52(7):1284-93. PubMed ID: 16690735
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous multi-analyte urinary protein assay for bladder cancer detection.
Rosser CJ; Dai Y; Miyake M; Zhang G; Goodison S
BMC Biotechnol; 2014 Apr; 14():24. PubMed ID: 24684904
[TBL] [Abstract][Full Text] [Related]
17. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
Eissa S; Labib RA; Mourad MS; Kamel K; El-Ahmady O
Eur Urol; 2003 Dec; 44(6):687-94. PubMed ID: 14644121
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two malaria multiplex immunoassays that enable quantification of malaria antigens.
Jang IK; Jiménez A; Rashid A; Barney R; Golden A; Ding XC; Domingo GJ; Mayor A
Malar J; 2022 Jun; 21(1):176. PubMed ID: 35672772
[TBL] [Abstract][Full Text] [Related]
19. Fast and Efficient Measurement of Clinical and Biological Samples Using Immunoassay-Based Multiplexing Systems.
Zhang Y; Li X; Di YP
Methods Mol Biol; 2020; 2102():129-147. PubMed ID: 31989552
[TBL] [Abstract][Full Text] [Related]
20. Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study.
Murakami K; Kamat AM; Dai Y; Pagano I; Chen R; Sun Y; Gupta A; Goodison S; Rosser CJ; Furuya H
Cancer Biomark; 2022; 33(1):151-157. PubMed ID: 34511488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
